What role do adaptive clinical trials play in regulatory changes?
Adaptive clinical trials allow for modifications to the trial protocols based on interim results without compromising the integrity of the study. These trials can adjust sample sizes, treatment regimens, and endpoints, providing a more flexible and efficient path to evaluating cancer treatments. This approach helps in identifying the most effective therapies faster and with fewer resources, aligning with regulatory efforts to expedite the approval process.
